Kevin Boyle, Alaunos Therapeutics CEO

Zio­pharm re­brands to Alaunos, clos­es Boston of­fice with new CEO at the reins

A lit­tle over a year af­ter fac­ing an ac­tivist at­tack that saw for­mer CEO Lau­rence Coop­er sur­vive but re­tire a few months lat­er, Zio­pharm On­col­o­gy …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.